• 1

    Kager PA, Schultz MJ, Zijlstra EE, van den Berg B, van Boxtel C, 1994. Arteether administration in humans: preliminary studies of pharmacokinetics, safety and tolerance. Trans R Soc Trop Med Hyg 88 :53–54.

    • Search Google Scholar
    • Export Citation
  • 2

    Toovey S, Jamieson A, 2004. Audiometric changes associated with the treatment of uncomplicated falciparum malaria with co-artemether. Trans R Soc Trop Med Hyg 98 :261–267.

    • Search Google Scholar
    • Export Citation
  • 3

    Toovey S, 2006. Effects of weight, age, and time on artemether-lumefantrine associated ototoxicity and evidence of irreversibility. Travel Med Infect Dis 4 :71–76.

    • Search Google Scholar
    • Export Citation
  • 4

    Claessen FA, van Boxtel CJ, Perenboom RM, Tange RA, Wetsteijn JC, Kager PA, 1998. Quinine pharmacokinetics: ototoxic and cardiotoxic effects in healthy Caucasian subjects and in patients with falciparum malaria. Trop Med Int Health 3 :482–489.

    • Search Google Scholar
    • Export Citation
  • 5

    Tange RA, Dreschler WA, Claessen FA, Perenboom RM, 1997. Ototoxic reactions of quinine in healthy persons and patients with Plasmodium falciparum infection. Auris Nasus Larynx 24 :131–136.

    • Search Google Scholar
    • Export Citation
  • 6

    Hutagalung R, Htoo H, Nwee P, Arunkamomkiri J, Zwang J, Carrara VI, Ashley E, Singhasivanon P, White NJ, Nosten F, 2006. A case-control auditory evaluation of patients treated with artemether-lumefantrine. Am J Trop Med Hyg 74 :211–214.

    • Search Google Scholar
    • Export Citation
  • 7

    Kissinger E, Hien TT, Hung NT, Nam ND, Tuyen NL, Dinh BV, Mann C, Phu NH, Loc PP, Simpson JA, White NJ, Farrar JJ, 2000. Clinical and neurophysiological study of the effects of multiple doses of artemisinin on brain-stem function in Vietnamese patients. Am J Trop Med Hyg 63 :48–55.

    • Search Google Scholar
    • Export Citation
  • 8

    van Vugt M, Angus BJ, Price RN, Mann C, Simpson JA, Poletto C, Htoo SE, Looareesuwan S, White NJ, Nosten F, 2000. A case-control auditory evaluation of patients treated with artemisinin derivatives for multidrug-resistant Plasmodium falciparum malaria. Am J Trop Med Hyg 62 :65–69.

    • Search Google Scholar
    • Export Citation
  • 9

    Toovey S, 2005. Reply to comment on: audiometric changes associated with the treatment of uncomplicated falciparum malaria with co-artemether. Trans R Soc Trop Med Hyg 99 :314–315.

    • Search Google Scholar
    • Export Citation
  • 10

    Toovey S, 2005. Reply to comment on: Audiometric changes associated with the treatment of uncomplicated falciparum malaria with co-artemether. Trans R Soc Trop Med Hyg 99 :316–317.

    • Search Google Scholar
    • Export Citation
  • 11

    Hien TT, Turner GD, Mai NT, Phu NH, Bethell D, Blakemore WF, Cavanagh JB, Dayan A, Medana I, Weller RO, Day NP, White NJ, 2003. Neuropathological assessment of artemether-treated severe malaria. Lancet 362 :295–296.

    • Search Google Scholar
    • Export Citation
  • 12

    Schmuck G, Roehrdanz E, Haynes RK, Kahl R, 2002. Neurotoxic mode of action of artemisinin. Antimicrob Agents Chemother 46 :821–827.

  • 13

    White NJ, Dondorp AM, Nosten F, Day NPJ, 2006. Artesunate versus quinine for severe falciparum malaria—authors’ reply. Lancet 367 :111–112.

    • Search Google Scholar
    • Export Citation
  • 14

    Franco-Paredes C, Dismukes R, Nicolls D, Kozarsky PE, 2005. Reply to Newton et al. Clin Infect Dis 41 :1688–1689.

 
 
 

 

 

 

 

 

 

A CASE-CONTROL AUDITORY EVALUATION OF PATIENTS TREATED WITH ARTEMETHER-LUMEFANTRINE

View More View Less
  • 1 Royal Free and University College Medical School, London, United Kingdom
Save